The biotechnology companies segment is anticipated to register a CAGR of 15.5% during the forecast period, driven by increasing development of next-generation metabolic disease therapies, dual- and multi-receptor agonists, and innovative peptide drug candidates requiring outsourced development and manufacturing support
Insurance coverage for GLP-1 medications has been expanding but remains inconsistent
The central melanocortin system is a neuro-immuno-endocrine hormone system that encompasses several central nervous system circuits 29 and controls various physiological functions, including food intake 29, 30
The Precision Peptide Genetic Test ($298) reveals your FTO, MC4R, GIPR variants, predicting whether you'll respond best to microdose initiation, standard titration, or dual-compound therapy
PMCID: PMC4496685
Dihexa acts primarily through hepatocyte growth factor (HGF) signaling by potentiating HGF/c-Met receptor interaction